[Federal Register Volume 78, Number 145 (Monday, July 29, 2013)]
[Page 45541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-18055]



National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of 

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
AIDS Research Advisory Committee, NIAID.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: AIDS Research Advisory Committee, NIAID; AIDS 
Vaccine Research Subcommittee.
    Date: September 18, 2013.
    Time: 8:30 a.m. to 12:30 p.m.
    Agenda: Presentations by the Vaccine Research Program staff on 
the preclinical, translational and clinical AIDS vaccine research 
programs supported by the Division of AIDS for the purpose of 
obtaining advice and guidance from the AVRS on future vaccine 
    Place: National Institutes of Health, Natcher Building, 
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: James A. Bradac, Ph.D., Chief, Preclinical 
Research and Development Branch, Division of AIDS, Room 5134, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, 
Bethesda, MD 20892-7628, 301-435-3754, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 22, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-18055 Filed 7-26-13; 8:45 am]